.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Cantor Fitzgerald
Julphar
Medtronic
US Army
Mallinckrodt
Colorcon
Cipla
McKinsey
Citi

Generated: November 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205373

« Back to Dashboard
NDA 205373 describes TRIAMCINOLONE ACETONIDE, which is a drug marketed by Mylan Pharms Inc, Taro, Parnell, Perrigo Israel, Teligent Pharma Inc, Pharmafair, Akorn, Perrigo New York, Alpharma Us Pharms, Glenmark Pharms Ltd, Glenmark Pharms, Watson Labs, G And W Labs Inc, Ambix, Wockhardt Eu Operatn, Wockhardt, Lupin Atlantis, Sandoz Inc, Fougera Pharms, Vintage, Lyne, Topiderm, Perrigo Uk Finco, Riconpharma Llc, Pharmaderm, Morton Grove, G And W Labs, Actavis Mid Atlantic, and Cmp Pharma Inc, and is included in seventy-seven NDAs. It is available from sixty-one suppliers. Additional details are available on the TRIAMCINOLONE ACETONIDE profile page.

The generic ingredient in TRIAMCINOLONE ACETONIDE is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Eighty-three suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.

Summary for 205373

Pharmacology for NDA: 205373

Medical Subject Heading (MeSH) Categories for 205373

Suppliers and Packaging for NDA: 205373

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRIAMCINOLONE ACETONIDE
triamcinolone acetonide
OINTMENT;TOPICAL 205373 ANDA Teligent Pharma, Inc. 52565-014 52565-014-15 1 TUBE in 1 CARTON (52565-014-15) > 15 g in 1 TUBE
TRIAMCINOLONE ACETONIDE
triamcinolone acetonide
OINTMENT;TOPICAL 205373 ANDA Teligent Pharma, Inc. 52565-014 52565-014-26 454 g in 1 JAR (52565-014-26)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrength0.1%
Approval Date:May 13, 2016TE:ATRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Fuji
Mallinckrodt
Moodys
Covington
Cantor Fitzgerald
Medtronic
Harvard Business School
Novartis
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot